Iranian Journal of Basic Medical Sciences

Iranian Journal of Basic Medical Sciences

Electroacupuncture ameliorates diabetic renal injury by regulating the AMPK-autophagy signaling pathway

Articles in Press

Document Type : Original Article

Authors
Zehao Zhang 1
Meijuan Xiang 2
Lejian Lan 2
Duo Peng 2
Lixia You 2
Mengmeng Jia 2
Jianyun Peng 2
1 The Nephrology Department of Xijing Hospital, The Fourth Military Medical University, Xi’an, Shaanxi 710032, China
2 Department of Nephrology, Lishui Hospital of Wenzhou Medical University, The First Affiliated Hospital of Lishui University, Lishui People’s Hospital, Lishui, Zhejiang 323000, China
10.22038/ijbms.2026.93505.20169
Abstract
Objective(s): Diabetic nephropathy (DN) is a common complication of diabetes mellitus (DM) and the leading cause of end-stage renal disease worldwide. Despite evidence supporting the renoprotective effects of electroacupuncture (EA), the underpinning molecular mechanisms require further investigation. This study was designed to evaluate the therapeutic efficacy of EA in mice with DN and to elucidate its potential mechanisms of action.
Materials and Methods: A DN model was established in male C57BL/6 mice by streptozotocin (STZ) injection and validated. Mice were randomly allocated into four groups: control, normal+electroacupuncture (EA), DN, and DN+EA. EA was applied at Yanglingquan and Zusanli acupoints in the treatment groups. Renal histology and ultrastructure were examined. AMPK and downstream autophagy-related molecule expression were analyzed by qRT-PCR and Western blot.
Results: Renal tissues from DN mice exhibited suppressed autophagy, marked by decreased microtubule-associated protein 1 light chain 3-II (LC3-II) and increased Sequestosome-1 (p62) expression, along with reduced phosphorylation of AMP-activated protein kinase (AMPK) and Unc-51 Like Autophagy Activating Kinase 1(ULK1) and increased Phosphorylated mammalian target of rapamycin (p-mTOR) levels after 8 weeks, indicating impaired autophagy and renal injury. EA treatment reversed these alterations by enhancing AMPK and ULK1 phosphorylation, restoring autophagy, and mitigating renal damage.
Conclusion: The AMPK signaling pathway represents a novel therapeutic target for DN. Our data indicate that EA facilitates renal protection by activating AMPK/ULK1-mediated autophagy, implicating EA as a viable strategy for targeting this pathway.
Keywords
AMP-activated protein- kinase
Autophagy
Diabetic nephropathy
Electroacupuncture
ULK1
Subjects
1. de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes management in chronic kidney disease: A consensus report by the american diabetes association (ADA) and kidney disease: Improving global outcomes (KDIGO). Diabetes Care 2022; 45: 3075-3090.
2. GBD 2023 Breast Cancer Collaborators. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the Global Burden of Disease Study 2021. Lancet 2023; 402: 203-234.
3. Glastras SJ, Pollock CA. Targeted identification of risk and treatment of diabetic kidney disease. Nat Rev Nephrol 2024; 20: 75-76.
4. Jung CY, Yoo TH. Pathophysiologic mechanisms and potential biomarkers in diabetic kidney disease. Diabetes Metab J 2022; 46: 181-197.
5. Li XJ, Shan QY, Wu X, Miao H, Zhao YY. Gut microbiota regulates oxidative stress and inflammation: A double-edged sword in renal fibrosis. Cell Mol Life Sci 2024; 81: 480.
6. Balakumar P. Unleashing the pathological role of epithelial-to-mesenchymal transition in diabetic nephropathy: The intricate connection with multifaceted mechanism. World J Nephrol 2024; 13: 95410.
7. Hou Y, Tan E, Shi H, Ren X, Wan X, Wu W, et al. Mitochondrial oxidative damage reprograms lipid metabolism of renal tubular epithelial cells in the diabetic kidney. Cell Mol Life Sci 2024; 81: 23.
8. Feng L, Feng YY, Ren Q, Fu P, Ma L. Mesangial cells in diabetic kidney disease: From mechanisms to therapeutic implications. Int J Biol Sci 2025; 21: 4762-4781.
9. Thompson AD, Hurtado KA, Janda J, Scholpa NE, Rohrer B, Schnellmann RG. MC16 promotes mitochondrial biogenesis and ameliorates acute and diabetic nephropathy. Br J Pharmacol 2025; 182: 1912-1929.
10. Zhao H, Guo J. Macrophages in focus: Key drivers and therapeutic opportunities in diabetic kidney disease. Int J Biol Sci 2025; 21: 4647-4662.
11. Ortega MA, Fraile-Martinez O, de Leon-Oliva D, Boaru DL, Lopez-Gonzalez L, García-Montero C, et al. Autophagy in its (proper) context: Molecular basis, biological relevance, pharmacological modulation, and lifestyle medicine. Int J Biol Sci 2024; 20: 2532-2554.
12. Florance I, Cordani M, Pashootan P, Moosavi MA, Zarrabi A, Chandrasekaran N. The impact of nanomaterials on autophagy across health and disease conditions. Cell Mol Life Sci 2024; 81: 184.
13. Wu MY, Li ZW, Lu JH. Molecular modulators and receptors of selective autophagy: Disease implication and identification strategies. Int J Biol Sci 2024; 20: 751-764.
14. Shi L, Song Z, Li C, Deng F, Xia Y, Huang J, et al. HDAC6 inhibition alleviates ischemia- and cisplatin-induced acute kidney injury by promoting autophagy. Cells 2022; 11: 3951.
15. Minami S, Yamamoto T, Yamamoto-Imoto H, Isaka Y, Hamasaki M. Autophagy and kidney aging. Prog Biophys Mol Biol 2023; 179: 10-15.
16. Erekat NS. Programmed cell death in diabetic nephropathy: A review of apoptosis, autophagy, and necroptosis. Med Sci Monit 2022; 28: e937766.
17. Zheng Z, Chen J, Xue X, Ma X, Zhang S, Wang M, et al. SESN2 inhibits tubular exosome secretion and diabetic kidney disease progression by restoring the autophagy‒lysosome pathway. Int J Biol Sci 2025; 21: 4215-4230.
18. North BJ, Fracchiolla D, Ragusa MJ, Martens S, Shoemaker CJ. The rapidly expanding role of LC3-interacting regions in autophagy. J Cell Biol 2025; 224: e202504076.
19. Xiao S, Yu Y, Liao M, Song D, Xu X, Tian L, et al. Post-translational modification of p62: Roles and regulations in autophagy. Cells. 2025; 14: 1016.
20. Tang C, Deng X, Qu J, Miao Y, Tian L, Zhang M, et al. Fenofibrate attenuates renal tubular cell apoptosis by up-regulating MCAD in diabetic kidney disease. Drug Des Devel Ther 2023; 17: 1503-1514.
21. Juszczak F, Caron N, Mathew AV, Declèves AE. Critical role for AMPK in metabolic disease-induced chronic kidney disease. Int J Mol Sci 2020; 21: 7994.
22. Rogacka D, Audzeyenka I, Piwkowska A. Regulation of podocytes function by AMP-activated protein kinase. Arch Biochem Biophys 2020; 692: 108541.
23. Wen J, Zheng W, Zeng L, Wang B, Chen D, Chen Y, et al. LTF induces radioresistance by promoting autophagy and forms an AMPK/SP2/NEAT1/miR-214-5p feedback loop in lung squamous cell carcinoma. Int J Biol Sci 2023; 19: 1509-1527.
24. Li B, Wu GL, Dai W, Wang G, Su HY, Shen XP, et al. Aescin-induced reactive oxygen species play a pro-survival role in human cancer cells via ATM/AMPK/ULK1-mediated autophagy. Acta Pharmacol Sin 2018; 39: 1874-1884.
25. Cho W, Oh H, Choi SW, Abd El-Aty AM, Birdal O, Jeong JH, et al. CTRP4 attenuates apoptosis and epithelial-mesenchymal transition markers in podocytes through an AMPK/autophagy-dependent pathway. Biochem Biophys Res Commun 2023; 682: 104-110.
26. Galluzzi L, Green DR. Autophagy-independent functions of the autophagy machinery. Cell 2019; 177: 1682-1699.
27. Xin YY, Wang JX, Xu AJ. Electroacupuncture ameliorates neuroinflammation in animal models. Acupunct Med 2022; 40: 474-483.
28. Liu S, Ge J, Liu W, Zhuang Z, Liu S. Involvement of the somatosensory-autonomic reflex and muscarinic receptors in exacerbation of allergic pulmonary inflammation by electroacupuncture. Br J Pharmacol 2025; 182: 2374-2391.
29. Han X, Gao Y, Yin X, Zhang Z, Lao L, Chen Q, et al. The mechanism of electroacupuncture for depression on basic research: A systematic review. Chin Med 2021; 16: 10.
30. Hu L, Klein JD, Hassounah F, Cai H, Zhang C, Xu P, et al. Low-frequency electrical stimulation attenuates muscle atrophy in CKD--a potential treatment strategy. J Am Soc Nephrol 2015; 26: 626-635.
31. Paterno JC, Freire AO, Soares MF, Franco MF, Schor N, Teixeira VP. Electroacupuncture and moxibustion attenuate the progression of renal disease in 5/6 nephrectomized rats. Kidney Blood Press Res 2008; 31: 367-373.
32. Harpin D, Simadibrata CL, Mihardja H, Barasila AC. Effect of electroacupuncture on urea and creatinine levels in the wistar sepsis model. Med Acupunct 2020; 32: 29-37.
33. Guo ZY, Wu X, Zhang SJ, Yang JH, Miao H, Zhao YY. Poria cocos: Traditional uses, triterpenoid components and their renoprotective pharmacology. Acta Pharmacol Sin 2025; 46: 836-851.
34. Feng HY, Wang YQ, Yang J, Miao H, Zhao YY, Li X. Anthraquinones from rheum officinale ameliorate renal fibrosis in acute kidney injury and chronic kidney disease. Drug Des Devel Ther 2025; 19: 5739-5760.
35. Wang YN, Wu X, Shan QY, Yang Q, Yu XY, Yang JH, et al. Acteoside-containing caffeic acid is bioactive functional group of antifibrotic effect by suppressing inflammation via inhibiting AHR nuclear translocation in chronic kidney disease. Acta Pharmacol Sin 2025; 46: 2975-2988.
36. Liang J, Sun J, Zhang W, Wang X, Xu Y, Peng Y, et al. Novel insights into the roles of N(6)-methyladenosine (m(6)A) modification and autophagy in human diseases. Int J Biol Sci 2023; 19: 705-720.
37. Huang Y, Zhang R, Lyu H, Xiao S, Guo D, Chen XZ, et al. LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance. Int J Biol Sci 2024; 20: 2698-2726.
38. Xiong W, He FF, You RY, Xiong J, Wang YM, Zhang C, et al. Acupuncture application in chronic kidney disease and its potential mechanisms. Am J Chin Med 2018; 46: 1169-1185.
39. Wang YN, Miao H, Yu XY, Guo Y, Su W, Liu F, et al. Oxidative stress and inflammation are mediated via aryl hydrocarbon receptor signalling in idiopathic membranous nephropathy. Free Radic Biol Med 2023; 207: 89-106.
40. Liu Y, Qiao Y, Pan S, Chen J, Mao Z, Ren K, et al. Broadening horizons: The contribution of mitochondria-associated endoplasmic reticulum membrane (MAM) dysfunction in diabetic kidney disease. Int J Biol Sci 2023; 19: 4427-4441.
41. Wang YN, Li XJ, Wang WF, Zou L, Miao H, Zhao YY. Geniposidic acid attenuates chronic tubulointerstitial nephropathy through regulation of the NF-ƙB/Nrf2 pathway via aryl hydrocarbon receptor signaling. Phytother Res 2024; 38: 5441-5457.
42. Liu X, Wang X, Ma H, Zhang W. Mechanisms underlying acupuncture therapy in chronic kidney disease: A narrative overview of preclinical studies and clinical trials. Front Nephrol 2022; 2: 1006506.
43. Tseng CH, Shah KM, Chiu IJ, Hsiao LL. The role of autophagy in type 2 diabetic kidney disease management. Cells 2023; 12: 2691.
44. Huang SS, Ding DF, Chen S, Dong CL, Ye XL, Yuan YG, et al. Resveratrol protects podocytes against apoptosis via stimulation of autophagy in a mouse model of diabetic nephropathy. Sci Rep 2017; 7: 45692.
45. Yuan Y, Wang F, Liu X, Shuai B, Fan H. The role of AMPK signaling in ulcerative colitis. Drug Des Devel Ther 2023; 17: 3855-3875.
46. Sun MY, Ye HJ, Zheng C, Jin ZJ, Yuan Y, Weng HB. Astragalin ameliorates renal injury in diabetic mice by modulating mitochondrial quality control via AMPK-dependent PGC1α pathway. Acta Pharmacol Sin 2023; 44: 1676-1686.
47. Kuang BC, Wang ZH, Hou SH, Zhang J, Wang MQ, Zhang JS, et al. Methyl eugenol protects the kidney from oxidative damage in mice by blocking the Nrf2 nuclear export signal through activation of the AMPK/GSK3β axis. Acta Pharmacol Sin 2023; 44: 367-380.
48. Wang S, Li H, Yuan M, Fan H, Cai Z. Role of AMPK in autophagy. Front Physiol 2022; 13: 1015500.
49. Xu TT, Deng YY, Yu XY, Li M, Fu YY. Natural autophagy modulators in non-communicable diseases: From autophagy mechanisms to therapeutic potential. Acta Pharmacol Sin 2025; 46: 8-32.
Iranian Journal of Basic Medical Sciences

Articles in Press, Accepted Manuscript
Available Online from 28 July 2026